Antibodies to hepatitis C and other viral markers in multi-transfused patients from Argentina

Journal of Clinical Virology

Volumn 34, Issue SUPPL. 2, 2005, Pages

  Remesar, Mirta ^a   Gamba, Cecilia ^a   Kuperman, Silvina ^a   Marcos, María Angélica ^a   Miguez, Gabriela ^b   Caldarola, Sergio ^b   Pérez Bianco, Raúl ^c   Manterola, Alberto ^a   Del Pozo, Ana ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Argentina; HCV antibodies; Multi transfused patients; Transfusion transmitted infections

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HEMODIALYSIS; HEMOGLOBINOPATHY; HEMOPHILIA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; TORQUE TENO VIRUS; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGENTINA; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HEMOPHILIA A; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 32044448150     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(05)80030-7     Document Type: Article

References (29)

1. Alter H.J., Purcell R.H., and Shin L.W. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis N Engl J Med 321 1989 1494 1500
2. Barrera J.M., Bruguera M., Ercilla M.G., Gil C., Celis R., and Gil M.P. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C Hepatology 21 1995 639 644
3. Chang T.T., Liou T.C., Young K.C., Lin C.Y., Shin J.S., and Wu H.L. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission J Med Virol 42 1994 91 96
4. Christensen P.H., Groenbaek K., and Krarup H.B. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV Lookback Group Transfusion 39 2 1999 188 193
5. Dean A.G., Dean J.A., Coulombier D., Brendel K.A., Smith D.C., and Burton A.L.L. EpiInfo, Version 6: A Word Processing, Database, and Statistics Program for Public Health on IBM-compatible microcomputers 1995 Center for Disease Control and Prevention
6. Donahue J.G., Muñoz A., Ness P.M., Brown D.E., Yawn D.H., and McAllister H.A. The declining risk of post-transfusion hepatitis C virus infection N Eng J Med 327 1992 369 373
7. Esteban J.I., Esteban R., and Viladomiu L. Hepatitis C virus antibodies among risk groups in Spain Lancet 2 1989 294 296
8. Fainboim H., Gonzalez J., Fassio E., Martinez A., Otegui L., and Eposto M. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study J Viral Hepat. 6 1 1999 53 57
9. Hernândez-Avila M., Garrido-La Torre F., and López-Moreno S. Diseno de estudios epidemiolologicos Salud Publica de Mexico 42 2 2000 144 154
10. Klein R.S., Freeman K., Taylor P.E., and Stevens C.E. Occupational risks for hepatitis C virus infection among New York City dentists Lancet 338 1991 1539 1542
11. Koretz R.L., Abbey H., Coleman E., and Gitnick G. Non-A, non-B posttransfusion hepatitis. Looking back in the second decade Ann Intern Med 119 1993 110 115
12. Lin H.H., Kao J.H., and Hsu H.Y. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus J Infect Dis 169 1994 638 641
13. Morfini M., Mannucci P., Ciavarella N., Schiavoni M., Gringeri A., and Rafanelli D. Prevalence of infection with the hepatitis C virus among Italian haemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation Vox Sang 67 2 1994 178 182
14. Nakagiri I., Ichihara K., and Ohmoto K. Analysis of discordant test results among five second-generation assays for anti-hepatitis C virus antibodies also tested by polymerase chainreaction-RNA assay and other laboratory and clinical tests for hepatitis J Clin Microbiol 31 1993 2974 2980
15. Picchio G.R., Nakatsuno M., Boggiano C., Sabbe R., Corti M., and Daruich J. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection J Med Viral. 52 2 1997 219 225
16. Richards C., Holland P., and Kuramoto K. Prevalence of antibody to hepatitis C virus in a blood donor population Transfusion 31 1991 109 113
17. Schmuñis G.A., Zicker F., Segura E.L., and del Pozo A.E. Transfusion-transmitted infectious diseases in Argentina, 1995 through 1997 Transfusion 40 9 2000 1048 1053
18. for the retrovirus epidemiology donor study Schreiber G.B., Busch M.P., Klieman S.H., and Korelitz J.J. The risk of transfusion-transmitted viral infection N Engl J Med 334 1996 1685 1690
19. Schujman L., Lavitula S., Maris Acebal S., Suita G.R., and Montero A. Relative risk of hepatitis C virus transmission in polytransfused patients Medicina (Buenos Aires) 54 3 1994 199 202
20. Smith B.C., Chapman C.E., Burt A.D., Toms G.L., and Bassendine M.E. Outcome of posttransfusion hepatitis C: disease severity in blood-components recipients and their implicated donors Q J Med 90 1997 587 592
21. Soldan K., Ramsay M., Robinson A., Harris H., Anderson N., and Caffrey E. The contribution of transfusion to HCV infection in England Epidemiol Infect 129 3 2002 587 591
22. Tobler L.H., Stramer S.L., Lee S.R., Masecar B.L., Peterson J.E., and Davis E.A. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening Transfusion 43 10 2003 1452 1459
23. Uyttendaele S., Claeys H., and Mertens W. Evaluation of third-generation screening and confirmatory assays for HCV antibodies Vox Sang 66 1994 122 129
24. Visonâ K., Baez F., Taylor L., Berrios R., León B., and Pacheco C. Impact of hepatitis B and hepatitis C virus infections in a hematology-oncology unit at a children's hospital in Nicaragua, 1997 to 1999 Clin Diag Lab Immunol 9 3 2002 622 626
25. Weinstock H.S., Bolan G., Reingold A.L., and Polish L.B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases JAMA 269 1993 392 394
26. Weissenbacher M., Rossi D., Radulich G., Sosa-Estani S., Vila M., and Vivas E. High seroprevalence of bloodbome viruses among street-recruited injection drug users from Buenos Aires, Argentina Clin Infect Dis. 37 Suppl 5 2003 S348 S352
27. WHO Weekly Epidemiological Record: Revised recommendation for the selection an use of HIV antibody tests WHO Wkly Epidemiol Rec 72 1997 81 88
28. WHO Weekly Epidemiological Record: Hepatitis C: global prevalence WHO Wkly Epidemiol Rec 72 1997 341 344
29. WHO/EMC/97.3 WHO Guia para et transporte seguro de substancias infecciosas y especímenes diagnósticos 1997 División para la vigilancia y et control de enfermedades emergentes y otras enfermedades transmisibles, Organización Mundial de la Salud Atlanta, Georgia, USA